2011年生物仿制药会议(Biosimilars Asia 2011)

作者:   2011-06-07
字体大小:
  • 会议时间: 2011-05-24至 2011-06-26
  • 会议地点: 上海
  • 电话:
  • 传真:
  • 联系人:
  • Email:
  • 联系地址:
  • 会议网址:

时间:2011-5-23 至 2011-5-26

    地点:Grand Hyatt Shanghai

    主办单位: IBC Asia (S) Pte Ltd

    会议简介

    According to Business Insights, an estimated $25bn worth of biologics will lose patent protection by 2016, creating a significant market opportunity for biosimilars. However, the reality is that biosimilar development is a risk-fraught activity that demands significant resources in R&D, manufacturing expertise, regulatory know-how, clinical-trial capabilities, and a high level of financial investment.
    Biosimilar development is riddled with complexities, ranging from regulatory, to manufacturing to marketing, and is one of the most expensive propositions in the pharmaceutical industry. It is estimated that it costs between US$100-200 million to bring a biosimilar product to market. With so much at stake, biosimilars represent not only substantial growth but equally risk..
    IBC’s 2nd Annual Biosimilars Asia 2011 Summit is the ONLY conference in Asia catering to this region’s specific queries. With unprecedented insights from leading innovators and biosimilar companies, you will network and learn how to strategically position your company to maximize your ROI. Biosimilars Asia 2011 is attended by key stakeholders in the region and beyond, enabling you to make informed strategic decisions.

编辑:   

声明:

1.丁香会议频道仅负责发布会议信息,如需参会、获取邀请函或会议日程,请与主办单位联系

2.部分会议信息来自互联网,如您发现信息有误,请联系meeting@dxy.cn纠错

3.如您发现信息不全,可点击Google搜索更多

4.更多服务信息请点击这里